|
WO2007051920A1
|
|
Methanone compounds and the use thereof in pharmaceutical compositions, in particular for treating cardiovascular diseases
|
|
WO2004091603A1
|
|
Use of an ester of dha for the treatment of cardiovascular diseases
|
|
FR2865732A1
|
|
Hydrazid-type compounds and their use in pharmaceutical compositions for the treatment of cardiovascular diseases
|
|
FR2857265A1
|
|
Medicaments for combating diseases involving matrix metalloproteases, TolR4 receptor and/or CD36, especially arteriosclerosis or hypercholesterolemia, containing docosahexaenoic acid esters
|
|
WO03093826A2
|
|
Assays for identifying cholesterol - lowering molecules
|
|
EP1466597A1
|
|
Use of dha esters to control or prevent cardiovascular diseases
|
|
EP1431399A1
|
|
Methods and composition for identifying therapeutic agents of atherosclerotic plaque lesions
|
